OMED26 is Oct. 22-25 in Las Vegas! Earn up to 60 CME credits at the osteopathic profession’s premier event. | REGISTER NOW

JOM

Investigating biomarkers associated with mortality in patients receiving VA-ECMO for cardiogenic shock: a systematic review

By JOM Staff

07.09.26

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a life-sustaining therapy for severe refractory cardiogenic shock. Although VA-ECMO provides various degrees of cardiopulmonary support, mortality rates remain high. Serum biomarkers have potential to identify the rising risk of mortality in patients receiving ECMO, but evidence supporting their prognostic value is inconsistent.